Morning Edition · №
Film · Documentary

Nathan Fielder's Elizabeth Holmes Documentary Stuns With a Record Specialty Box Office Debut

"You Can See Everything," made with unusual access to the disgraced Theranos founder in the weeks before she reported to prison, opened to one of the year's strongest per-theater averages — and A24 is about to widen it nationwide.

Nathan Fielder's Elizabeth Holmes Documentary Stuns With a Record Specialty Box Office Debut
An empty theater ahead of a screening — illustrative; not the actual Telluride premiere. — Photograph: Toni Pomar / Unsplash
SHARE X f in ⧉

"You Can See Everything," the Nathan Fielder-Lance Oppenheim documentary that follows Elizabeth Holmes through the final weeks before she reported to federal prison, opened in limited release over the weekend to roughly $15.6 million from just 855 theaters — a per-theater average of about $18,200, among the strongest specialty debuts of the year. A24, which is distributing the film, expanded it from a surprise addition at the Telluride Film Festival in September into a platform release on October 16, with a nationwide expansion set for October 23.

The number stands out against the weekend's widest release: the "Street Fighter" reboot opened in roughly 3,575 theaters and still managed only about $8,600 per theater on its way to a $30.8 million debut. "You Can See Everything" ran 174 minutes, carries an R rating for language and graphic nudity, and has no confirmed streaming date, though industry estimates point to early 2027 on HBO Max given A24's usual distribution pattern.

A Deadpan Portrait of Denial

The film's premise is almost absurdly simple on paper: thirty-four days before she was due to report to prison, Holmes — convicted of defrauding investors over Theranos's blood-testing technology — invited a documentary crew to record her daily life. What Fielder and Oppenheim built from that access has split critics less on quality than on how to read its subject. Early reviews have been largely enthusiastic; a WBUR review called it a "gut-busting cringe comedy" that doubles as a philosophical inquiry into perception, while an Associated Press review carried by ABC News described it as a staggering piece of performance art by everyone involved, Holmes included.

Several critics have stressed that the film does not argue Holmes is innocent. Instead, it sits with the question of why she still appears to believe her own account of what happened at Theranos — a tension that both of the film's directors have built entire careers on exploring. Fielder's "The Rehearsal" and "Nathan For You" turned deadpan, elaborately staged interventions into their own genre; Oppenheim's prior documentary work has similarly specialized in subjects who seem only partly aware of how they're being seen.

From a Surprise Premiere to a Nationwide Run

The film's Telluride debut in early September was not publicly announced in advance, adding to the word-of-mouth that has followed it into its commercial release. Several reviewers have specifically urged audiences to see it without reading detailed plot summaries first, arguing that its effect depends partly on not knowing exactly what Holmes will say or do on camera.

With a nationwide expansion scheduled for October 23 — the same week "Street Fighter" and "You Can See Everything" will effectively be trading places on multiplex marquees — distributors and awards strategists will be watching whether the film's eye-popping per-screen average holds up once it leaves its initial specialty runs in major cities. A24 has not announced a streaming date.

SHARE THIS ARTICLE X Facebook LinkedIn Copy link
Carla Ferro · Culture Correspondent

Writes on culture for UBStandard — art, books, exhibitions and the ideas moving through Europe's cultural capitals.

[email protected]
Related coverage Front page →